Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMpassion130: Atezolizumab + Nab-Paclitaxel in TNBC
NCT02425891Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2015
- Primary completion
- Apr 2020
- Modality
- Monoclonal Antibodies
- Countries
- 40
01
Overview
A Phase 3 trial of atezolizumab in triple-negative breast cancer (TNBC), sponsored by Roche. Started Jun 2015; status: completed.
02
Drugs
atezolizumab
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02425891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425891.